Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of rebeccamycin analogue in treating children who
have solid tumors or non-Hodgkin's lymphoma. Drugs used in chemotherapy use different ways to
stop cancer cells from dividing so they stop growing or die.